# RadNet, Inc.: filings

RDNT · Nasdaq · CIK 790526 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rdnt.md) · [Financials](/companies/rdnt/financials.md) · [Filings](/companies/rdnt/filings.md) · [Insiders](/companies/rdnt/insiders.md)

## Reports and events: 296 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 573, 8-K 169, 10-Q 53, 144 43, 4/A 34, SC 13G/A 34, 425 24, 10-K 18, DEF 14A 18, 3 14, SC 13D/A 13, SC 13G 12, 8-K/A 11, 10-K/A 10, UPLOAD 10, CORRESP 9, DEFA14A 8, S-8 8, 424B7 7, 424B5 4, 5 4, ARS 4, EFFECT 4, SCHEDULE 13G/A 4, S-3ASR 3, SC 13D 3, SCHEDULE 13G 3, 424B3 2, PRE 14A 2, S-4 2, S-4/A 2, 10-Q/A 1, 3/A 1, 5/A 1, CT ORDER 1, DEFR14A 1, NT 10-K 1, NT 10-Q 1, POS AM 1, PRER14A 1, PX14A6G 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:11 ET | [8-K](/filings/0001683168-26-008094.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-008094 |
| 2026-08-14 | 16:17 ET | [8-K](/filings/0001683168-26-006479.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-006479 |
| 2026-08-10 | 17:06 ET | [10-Q](/filings/0001628280-26-055338.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055338 |
| 2026-08-10 | 06:07 ET | [8-K](/filings/0001683168-26-006125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-006125 |
| 2026-06-10 | 17:23 ET | [8-K](/filings/0001683168-26-004716.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-004716 |
| 2026-06-04 | 21:08 ET | [8-K](/filings/0001683168-26-004522.md) | 5.07 Shareholder vote results | 0001683168-26-004522 |
| 2026-06-03 | 08:07 ET | [8-K](/filings/0001683168-26-004475.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-004475 |
| 2026-05-11 | 16:40 ET | [10-Q](/filings/0001628280-26-033607.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033607 |
| 2026-05-11 | 07:24 ET | [8-K](/filings/0001683168-26-003624.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-003624 |
| 2026-04-20 | 17:15 ET | [DEF 14A](/filings/0001683168-26-003086.md) | Proxy statement, period 2026-06-02 | 0001683168-26-003086 |
| 2026-03-02 | 17:17 ET | [10-K](/filings/0001628280-26-013337.md) | Annual report, period 2025-12-31 | 0001628280-26-013337 |
| 2026-03-02 | 07:01 ET | [8-K](/filings/0001683168-26-001385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-001385 |
| 2026-03-02 | 07:00 ET | [8-K](/filings/0001683168-26-001384.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-001384 |
| 2026-01-30 | 16:17 ET | [8-K](/filings/0001683168-26-000636.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-000636 |
| 2026-01-09 | 16:15 ET | [8-K](/filings/0001683168-26-000190.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-000190 |
| 2025-12-04 | 17:29 ET | [8-K](/filings/0001683168-25-008900.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-008900 |
| 2025-11-10 | 16:07 ET | [10-Q](/filings/0000790526-25-000008.md) | Quarterly report, period 2025-09-30 | 0000790526-25-000008 |
| 2025-11-10 | 08:30 ET | [8-K](/filings/0001683168-25-008100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-008100 |
| 2025-10-21 | 16:17 ET | [8-K](/filings/0001683168-25-007694.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-007694 |
| 2025-08-11 | 16:37 ET | [10-Q](/filings/0001628280-25-039605.md) | Quarterly report, period 2025-06-30 | 0001628280-25-039605 |
| 2025-08-11 | 06:09 ET | [8-K](/filings/0001683168-25-005844.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-005844 |
| 2025-07-17 | 16:30 ET | [8-K](/filings/0001683168-25-005180.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-005180 |
| 2025-06-12 | 16:20 ET | [8-K](/filings/0001683168-25-004440.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-004440 |
| 2025-05-12 | 16:09 ET | [10-Q](/filings/0001628280-25-024672.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024672 |
| 2025-05-12 | 09:03 ET | [8-K](/filings/0001683168-25-003385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003385 |
| 2025-04-28 | 06:19 ET | [DEF 14A](/filings/0001683168-25-002862.md) | Proxy statement, period 2025-06-10 | 0001683168-25-002862 |
| 2025-04-28 | 06:07 ET | [10-K/A](/filings/0001683168-25-002860.md) | Annual report, amended, period 2024-12-31 | 0001683168-25-002860 |
| 2025-04-15 | 16:12 ET | [8-K](/filings/0001683168-25-002591.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-002591 |
| 2025-03-05 | 15:11 ET | [8-K](/filings/0001683168-25-001349.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-001349 |
| 2025-03-03 | 17:00 ET | [10-K](/filings/0001628280-25-009481.md) | Annual report, period 2024-12-31 | 0001628280-25-009481 |
| 2024-11-26 | 17:28 ET | [8-K](/filings/0001683168-24-008404.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-24-008404 |
| 2024-11-12 | 17:06 ET | [10-Q](/filings/0001628280-24-047285.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047285 |
| 2024-11-12 | 16:55 ET | [8-K](/filings/0001683168-24-007907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007907 |
| 2024-10-11 | 18:26 ET | [8-K](/filings/0001683168-24-007058.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007058 |
| 2024-09-12 | 16:41 ET | [8-K](/filings/0001683168-24-006338.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-24-006338 |
| 2024-08-09 | 16:25 ET | [8-K](/filings/0001683168-24-005428.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005428 |
| 2024-08-09 | 16:05 ET | [10-Q](/filings/0001628280-24-036466.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036466 |
| 2024-06-13 | 16:55 ET | [8-K](/filings/0001683168-24-004201.md) | 5.07 Shareholder vote results | 0001683168-24-004201 |
| 2024-05-13 | 18:58 ET | [8-K](/filings/0001683168-24-003246.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003246 |
| 2024-05-10 | 16:06 ET | [10-Q](/filings/0001628280-24-022619.md) | Quarterly report, period 2024-03-31 | 0001628280-24-022619 |
| 2024-04-26 | 16:05 ET | [DEF 14A](/filings/0001683168-24-002737.md) | Proxy statement, period 2024-06-12 | 0001683168-24-002737 |
| 2024-04-18 | 17:04 ET | [8-K](/filings/0001683168-24-002513.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-24-002513 |
| 2024-04-11 | 06:15 ET | [8-K](/filings/0001683168-24-002291.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-002291 |
| 2024-04-03 | 08:20 ET | [8-K](/filings/0001683168-24-002073.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-002073 |
| 2024-03-12 | 16:18 ET | [8-K](/filings/0001683168-24-001430.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-001430 |
| 2024-03-05 | 14:08 ET | [8-K](/filings/0001683168-24-001310.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-001310 |
| 2024-02-29 | 16:57 ET | [10-K](/filings/0001628280-24-008035.md) | Annual report, period 2023-12-31 | 0001628280-24-008035 |
| 2024-01-05 | 16:14 ET | [8-K](/filings/0001683168-24-000099.md) | 5.02 Departure or appointment of officers or directors | 0001683168-24-000099 |
| 2023-11-13 | 07:16 ET | [8-K](/filings/0001683168-23-007874.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-007874 |
| 2023-11-09 | 17:22 ET | [10-Q](/filings/0001628280-23-038345.md) | Quarterly report, period 2023-09-30 | 0001628280-23-038345 |

Page 1 of 6. [Older](/companies/rdnt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:12 ET. No prices; not investment advice.